Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001011438-26-000180·Doma Perpetual Capital Management LLC
Schedule 13D ownership disclosure
Pacira BioSciences Inc
Common Stock, par value $0.001 per share · CUSIP: 695127100
Event date: 2026-03-11
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- DOMA PERPETUAL CAPITAL MANAGEMENT LLCReported CIK 0001962221
Shares: 2,777,794 · Class: 6.9%
- DOMA1 LLC
Shares: 2,777,794 · Class: 6.9%
- DOMA Perpetual LO Equity Master Fund LP
Shares: 1,965,775 · Class: 4.9%
- DOMA Perpetual Partners GP LLC
Shares: 1,965,775 · Class: 4.9%
- Pedro Escudero
Shares: 2,936,794 · Class: 7.3%
- The John Templeton Foundation
Shares: 812,019 · Class: 2%
- DOMA2 LLC
Shares: 1,965,775 · Class: 4.9%
- Eric de Armas
Shares: 1,389 · Class: 0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001011438-26-000180
- Form type
- SCHEDULE 13D/A
- Filer
- Doma Perpetual Capital Management LLC
- CIK
- CIK 1962221
- Filed
- Mar 12, 2026
- Reporting period
- Mar 11, 2026
- Description
- Schedule 13D beneficial ownership